223 related articles for article (PubMed ID: 24522914)
21. Rhesus lymphocryptovirus type 1-associated B-cell nasal lymphoma in SIV-infected rhesus macaques.
Marr-Belvin AK; Carville AK; Fahey MA; Boisvert K; Klumpp SA; Ohashi M; Wang F; O'Neil SP; Westmoreland SV
Vet Pathol; 2008 Nov; 45(6):914-21. PubMed ID: 18984796
[TBL] [Abstract][Full Text] [Related]
22. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.
Rivailler P; Carville A; Kaur A; Rao P; Quink C; Kutok JL; Westmoreland S; Klumpp S; Simon M; Aster JC; Wang F
Blood; 2004 Sep; 104(5):1482-9. PubMed ID: 15150077
[TBL] [Abstract][Full Text] [Related]
23. Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
Rühl J; Citterio C; Engelmann C; Haigh T; Dzionek A; Dreyer J; Khanna R; Taylor GS; Wilson JB; Leung CS; Münz C
J Clin Invest; 2019 May; 129(5):2071-2087. PubMed ID: 31042161
[TBL] [Abstract][Full Text] [Related]
24. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors.
Dowell AC; Haigh TA; Ryan GB; Turner JE; Long HM; Taylor GS
PLoS Pathog; 2021 Dec; 17(12):e1010137. PubMed ID: 34882759
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.
Ruf IK; Moghaddam A; Wang F; Sample J
J Virol; 1999 Mar; 73(3):1980-9. PubMed ID: 9971778
[TBL] [Abstract][Full Text] [Related]
27. Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.
Edwards KR; Schmidt K; Homad LJ; Kher GM; Xu G; Rodrigues KA; Ben-Akiva E; Abbott J; Prlic M; Newell EW; De Rosa SC; Irvine DJ; Pancera M; McGuire AT
Cell Rep Med; 2024 May; ():101587. PubMed ID: 38781964
[TBL] [Abstract][Full Text] [Related]
28. A Novel Immunogen Selectively Eliciting CD8
Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
[TBL] [Abstract][Full Text] [Related]
29. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F
J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828
[TBL] [Abstract][Full Text] [Related]
31. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.
Helmold Hait S; Vargas-Inchaustegui DA; Musich T; Mohanram V; Tuero I; Venzon DJ; Bear J; Rosati M; Vaccari M; Franchini G; Felber BK; Pavlakis GN; Robert-Guroff M
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463978
[TBL] [Abstract][Full Text] [Related]
32. Rhesus lymphocryptovirus infection during the progression of SAIDS and SAIDS-associated lymphoma in the rhesus macaque.
Habis A; Baskin G; Simpson L; Fortgang I; Murphey-Corb M; Levy LS
AIDS Res Hum Retroviruses; 2000 Jan; 16(2):163-71. PubMed ID: 10659055
[TBL] [Abstract][Full Text] [Related]
33. Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization.
Mühe J; Wang F
PLoS Pathog; 2017 Dec; 13(12):e1006772. PubMed ID: 29261800
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
Kalra M; Gerdemann U; Luu JD; Ngo MC; Leen AM; Louis CU; Rooney CM; Gottschalk S
Cytotherapy; 2019 Feb; 21(2):212-223. PubMed ID: 30396848
[TBL] [Abstract][Full Text] [Related]
35. Increased mucosal CD4+ T cell activation in rhesus macaques following vaccination with an adenoviral vector.
Bukh I; Calcedo R; Roy S; Carnathan DG; Grant R; Qin Q; Boyd S; Ratcliffe SJ; Veeder CL; Bellamy SL; Betts MR; Wilson JM
J Virol; 2014 Aug; 88(15):8468-78. PubMed ID: 24829340
[TBL] [Abstract][Full Text] [Related]
36. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
Samreen B; Tao S; Tischer K; Adler H; Drexler I
Front Immunol; 2019; 10():2984. PubMed ID: 31921215
[TBL] [Abstract][Full Text] [Related]
37. Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.
Moghaddam A; Koch J; Annis B; Wang F
J Virol; 1998 Apr; 72(4):3205-12. PubMed ID: 9525646
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
39. Macaque homologs of EBV and KSHV show uniquely different associations with simian AIDS-related lymphomas.
Bruce AG; Bielefeldt-Ohmann H; Barcy S; Bakke AM; Lewis P; Tsai CC; Murnane RD; Rose TM
PLoS Pathog; 2012; 8(10):e1002962. PubMed ID: 23055934
[TBL] [Abstract][Full Text] [Related]
40. The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in
Martins MA; Gonzalez-Nieto L; Shin YC; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Pedreño-Lopez N; Bailey VK; Altman JD; Parks CL; Allison DB; Ejima K; Rakasz EG; Capuano S; Desrosiers RC; Lifson JD; Watkins DI
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
